Stay updated on Dupilumab in AFRS Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in AFRS Clinical Trial page.

Latest updates to the Dupilumab in AFRS Clinical Trial page
- Check4 days agoChange DetectedResults for NCT04684524 were posted on 2025-12-22. The page now includes an expanded list of participating sites across the United States and international locations, and study outcomes/endpoints have been updated.SummaryDifference5%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe study page now shows 'Results Submitted' and no longer shows 'No Results Posted', updating the results status for the AFRS study.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page revision was updated from v3.2.0 to v3.3.2. This metadata change does not affect study details or how the page is used.SummaryDifference0.0%

- Check40 days agoChange DetectedRemoved the government funding status notice, an administrative update that does not affect core study content such as eligibility criteria or trial endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check54 days agoChange DetectedThe Study Details page shows updated locations and revised study dates. These changes affect which sites are active and when enrollment and completion are expected.SummaryDifference0.3%

- Check83 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference3%

Stay in the know with updates to Dupilumab in AFRS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in AFRS Clinical Trial page.